Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IOVA

IOVA News

Newswire

10:39

Iovance shares surge 10.49% intraday as Barclays initiates buy rating with $9 target.

09:49

Iovance: Barclays Keeps Overweight Rating, Raises PT to $9 from $4.

08:33

Oncotelic Therapeutics' 45% Ownership in JV Partner GMP Bio Set to Receive Major Fair-Value Update

10:14

Iovance Biotherapeutics shares surge 11.81% intraday after Q3 earnings beat and positive tumor treatment trial results.

13:26

Iovance Biotherapeutics: Base-Case Q3 Report Keeps Investors in "Show Me" Mode

View More

About IOVA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More